These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34224067)

  • 1. Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities.
    Anyfanti P; Gavriilaki E; Nikolaidou B; Yiannaki E; Lazaridis A; Papadopoulos N; Douma S; Doumas M; Gkaliagkousi E
    J Thromb Thrombolysis; 2022 Jan; 53(1):10-16. PubMed ID: 34224067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of microvesicles from different cell origins in patients with psoriasis: evidence of thrombogenic, proinflammatory microenvironment in the absence of established cardiovascular disease.
    Margouta A; Anyfanti P; Lazaridis A; Gavriilaki E; Yiannaki E; Nikolaidou B; Goulas K; Lazaridou E; Triantafyllou A; Douma S; Patsatsi A; Gkaliagkousi E
    J Hum Hypertens; 2023 Oct; 37(10):925-930. PubMed ID: 36482197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease.
    Bryl-Górecka P; James K; Torngren K; Haraldsson I; Gan LM; Svedlund S; Olde B; Laurell T; Omerovic E; Erlinge D
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2147-H2160. PubMed ID: 33797274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation.
    Gavriilaki E; Sakellari I; Anyfanti P; Batsis I; Vardi A; Bousiou Z; Lazaridis A; Nikolaidou B; Zarifis I; Masmanidou M; Yiannaki E; Markala D; Anagnostopoulos A; Douma S; Gkaliagkousi E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis.
    Campello E; Zanetto A; Radu CM; Bulato C; Truma A; Spiezia L; Senzolo M; Garcia-Tsao G; Simioni P
    Dig Liver Dis; 2021 Jul; 53(7):879-888. PubMed ID: 33431230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation.
    Gkaliagkousi E; Gavriilaki E; Yiannaki E; Vasileiadis I; Nikolaidou B; Lazaridis A; Dolgyras P; Grigoriadis S; Triantafyllou A; Anyfanti P; Markala D; Zarifis I; Douma S
    J Thromb Thrombolysis; 2021 May; 51(4):1138-1143. PubMed ID: 33043416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications.
    Bergen K; Mobarrez F; Jörneskog G; Wallén H; Tehrani S
    Thromb Res; 2020 Dec; 196():78-86. PubMed ID: 32853980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells.
    Alexandru N; Andrei E; Safciuc F; Dragan E; Balahura AM; Badila E; Georgescu A
    Cells; 2020 Feb; 9(2):. PubMed ID: 32059493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors.
    Takeshita J; Mohler ER; Krishnamoorthy P; Moore J; Rogers WT; Zhang L; Gelfand JM; Mehta NN
    J Am Heart Assoc; 2014 Feb; 3(1):e000507. PubMed ID: 24584739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis.
    Chatterjee V; Yang X; Ma Y; Cha B; Meegan JE; Wu M; Yuan SY
    Cardiovasc Res; 2020 Jul; 116(8):1525-1538. PubMed ID: 31504252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvesicles from patients with acute coronary syndrome enhance platelet aggregation.
    Kafian S; Wallén H; Samad BA; Mobarrez F
    Scand J Clin Lab Invest; 2019 Nov; 79(7):507-512. PubMed ID: 31502883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?
    McCarthy EM; Wilkinson FL; Parker B; Alexander MY
    Vascul Pharmacol; 2016 Nov; 86():71-76. PubMed ID: 27291140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke.
    Rosińska J; Ambrosius W; Maciejewska J; Narożny R; Kozubski W; Łukasik M
    Thromb Res; 2019 Apr; 176():18-26. PubMed ID: 30763823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.
    Hamali HA; Saboor M; Dobie G; Madkhali AM; Akhter MS; Hakamy A; Al-Mekhlafi HM; Jackson DE; Matari YH; Mobarki AA
    Infect Drug Resist; 2022; 15():2359-2368. PubMed ID: 35517897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of circulating microvesicles derived from myocardial Ischemic preconditioning and cardioprotection of Ischemia/reperfusion Injury in rats.
    Liu M; Wang YL; Shang M; Wang Y; Zhang Q; Wang SX; Wei S; Zhang K; Liu C; Wu YN; Liu ML; Song JQ; Liu YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Nov; 31(6):524-31. PubMed ID: 27215020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvesicles as risk markers for venous thrombosis.
    Rautou PE; Mackman N
    Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.
    Mobarrez F; Abraham-Nordling M; Aguilera-Gatica K; Friberg I; Antovic A; Pisetsky DS; Jörneskog G; Wallen H
    Clin Endocrinol (Oxf); 2016 May; 84(5):729-35. PubMed ID: 26252432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Microvesicles Derived from NK Cells Stimulated with IL-1β on the Phenotype and Functional Activity of Endothelial Cells.
    Markova K; Mikhailova V; Milyutina Y; Korenevsky A; Sirotskaya A; Rodygina V; Tyshchuk E; Grebenkina P; Simbirtsev A; Selkov S; Sokolov D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway.
    Wu K; Yang Y; Zhong Y; Ammar HM; Zhang P; Guo R; Liu H; Cheng C; Koroscil TM; Chen Y; Liu S; Bihl JC
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E828-37. PubMed ID: 26956185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.